L01FF
Spain- L01FF01 2 medications
- L01FF02 1 medications
- L01FF03 2 medications
- L01FF04 1 medications
- L01FF05 3 medications
- L01FF06 1 medications
- L01FF07 1 medications
- L01FF09 1 medications
- L01FF12 1 medications
- L01FF13 1 medications
medicationsWithCode L01FF
-
Bavencio 20 mg/ml concentrate for infusion solution
Form: solution for infusion, concentrate
Active substance Dosage AVELUMAB 200 mg mg ATC code: L01F, L01FF, L01FF04
Manufacturer: Merck Europe B.V.
-
Hetronifly 10 mg/ml concentrate for infusion solution
Form: solution for infusion, concentrate
Active substance Dosage SERPLULIMAB 100 mg ATC code: L01F, L01FF, L01FF12
Manufacturer: Accord Healthcare S.L.U.
-
Imfinzi 50 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage DURVALUMAB 500 mg ATC code: L01F, L01FF, L01FF03
Manufacturer: Astrazeneca Ab
-
Imfinzi 50 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage DURVALUMAB 120 mg ATC code: L01F, L01FF, L01FF03
Manufacturer: Astrazeneca Ab
-
Jemperli 500 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage DOSTARLIMAB 500 mg ATC code: L01F, L01FF, L01FF07
Manufacturer: Glaxosmithkline Trading Services Limited
-
Keytruda 25 mg/ml concentrate for infusion solution
Form: solution for infusion, concentrate
Active substance Dosage PEMBROLIZUMAB 100 mg ATC code: L01F, L01FF, L01FF02
Manufacturer: Merck Sharp & Dohme B.V.
-
Libtayo 350 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage CEMIPLIMAB 350 mg ATC code: L01F, L01FF, L01FF06
Manufacturer: Regeneron Ireland Designated Activity Company
-
Loqtorzi 240 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage TORIPALIMAB 240 mg ATC code: L01F, L01FF, L01FF13
Manufacturer: Topalliance Biosciences Europe Limited
-
Opdivo 10 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage NIVOLUMAB 47 mg/dosis ATC code: L01F, L01FF, L01FF01
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Opdivo 10 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage NIVOLUMAB 107 mg/dosis ATC code: L01F, L01FF, L01FF01
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Tecentriq 1200 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage ATEZOLIZUMAB 1200 mg ATC code: L01F, L01FF, L01FF05
Manufacturer: Roche Registration Gmbh
-
Tecentriq 1875 mg solution for injection
Form: solution for injection
Active substance Dosage ATEZOLIZUMAB 1875 mg ATC code: L01F, L01FF, L01FF05
Manufacturer: Roche Registration Gmbh
-
Tecentriq 840 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage ATEZOLIZUMAB 840 mg ATC code: L01F, L01FF, L01FF05
Manufacturer: Roche Registration Gmbh
-
Tevimbra 100 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage TISLELIZUMAB 10 mg ATC code: L01F, L01FF, L01FF09
Manufacturer: Beone Medicines Ireland Limited